January 27, 2023
Medthority
Update on FDA Emergency Use Authorisation of Evusheld
The FDA has stated that AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab) is not curre... See more »
Johnson & Johnson: J&J Seeks To Erase Talc Fraud Class Claims As Too Late
Johnson & Johnson has told a New Jersey federal court that the sons of a deceased factory worker are too late in bringing class claims alleging the pharmaceutical giant falsely represented to courts and personal injury litigants that there was no evidence of its industrial talc containing asbestos.
Read full article »
January 27, 2023
Medthority
TRANSCEND CLL 004 trial of Breyanzi met primary endpoint of complete response rate in patients with relapsed or refractory chronic lymphocytic leukemia.
Bristol Myers Squibb announced topline results from ITRANSCEND CLL 004, a Phase I/II, open-label, sin... See more »
January 27, 2023
Medthority
Update on FDA Emergency Use Authorisation of Evusheld
The FDA has stated that AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab) is not curre... See more »
January 27, 2023
Medthority
TRANSCEND CLL 004 trial of Breyanzi met primary endpoint of complete response rate in patients with relapsed or refractory chronic lymphocytic leukemia.
Bristol Myers Squibb announced topline results from ITRANSCEND CLL 004, a Phase I/II, open-label, sin... See more »
Johnson & Johnson is a New Jersey-based firm that engages in research, manufacturing and sale of healthcare products including consumer, pharmaceutical and medical devices.
Read more